{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:46:47Z","timestamp":1769838407227,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05467-0","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T02:53:29Z","timestamp":1766976809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Suboptimal heart rate control despite beta-blocker use in coronary artery disease: evidence from the Fasa PERSIAN cohort"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-9430","authenticated-orcid":false,"given":"Mohammad Hosein","family":"Yazdanpanah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-0924","authenticated-orcid":false,"given":"Sina","family":"Bazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahareh","family":"Fakhraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Bahramali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Zarenezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nematollah","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Rostaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4826-2846","authenticated-orcid":false,"given":"Mojtaba","family":"Farjam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"5467_CR1","doi-asserted-by":"publisher","unstructured":"Global. Regional, and National burden of cardiovascular diseases and risk factors in 204 countries and Territories, 1990\u20132023. J Am Coll Cardiol. 2025.\u00a0https:\/\/doi.org\/10.1016\/j.jacc.2025.08.015.","DOI":"10.1016\/j.jacc.2025.08.015"},{"issue":"1","key":"5467_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5334\/gh.1429","volume":"20","author":"M Heidari-Foroozan","year":"2025","unstructured":"Heidari-Foroozan M, Farshbafnadi M, Golestani A, Younesian S, Jafary H, Rashidi MM, et al. National and subnational burden of cardiovascular diseases in Iran from 1990 to 2021: results from global burden of diseases 2021 study. Glob Heart. 2025;20(1):43.","journal-title":"Glob Heart"},{"key":"5467_CR3","unstructured":"Murray CJ, Lopez AD, World Health Organization. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: summary. World Health Organization; 1996."},{"issue":"7","key":"5467_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrcardio.2011.58","volume":"8","author":"KM Fox","year":"2011","unstructured":"Fox KM, Ferrari R. Heart rate: a forgotten link in coronary artery disease? Nat Reviews Cardiol. 2011;8(7):369\u201379.","journal-title":"Nat Reviews Cardiol"},{"issue":"10","key":"5467_CR5","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/eurheartj\/ehn123","volume":"29","author":"R Kolloch","year":"2008","unstructured":"Kolloch R, Legler UF, Champion A, Cooper-DeHoff RM, Handberg E, Zhou Q, et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the international VErapamil-SR\/trandolapril study (INVEST). Eur Heart J. 2008;29(10):1327\u201334.","journal-title":"Eur Heart J"},{"issue":"9641","key":"5467_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008;372(9641):817\u201321.","journal-title":"Lancet"},{"issue":"9","key":"5467_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","volume":"50","author":"K Fox","year":"2007","unstructured":"Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Sendon JLL, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50(9):823\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5467_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00392-013-0644-4","volume":"103","author":"EM Lonn","year":"2014","unstructured":"Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET\/TRANSCEND. Clin Res Cardiol. 2014;103(2):149\u201359.","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"5467_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.amjcard.2009.11.035","volume":"105","author":"JE Ho","year":"2010","unstructured":"Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the treating to new targets [TNT] trial). Am J Cardiol. 2010;105(7):905\u201311.","journal-title":"Am J Cardiol"},{"issue":"10","key":"5467_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","volume":"26","author":"A Diaz","year":"2005","unstructured":"Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26(10):967\u201374.","journal-title":"Eur Heart J"},{"key":"5467_CR11","volume-title":"StatPearls. StatPearls publishing copyright \u00a9 2025","author":"K Farzam","year":"2025","unstructured":"Farzam K, Jan A, Beta Blockers. StatPearls. StatPearls publishing copyright \u00a9 2025. Treasure Island (FL): StatPearls Publishing LLC; 2025."},{"key":"5467_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.amjcard.2021.08.005","volume":"158","author":"AG Arero","year":"2021","unstructured":"Arero AG, Vasheghani-Farahani A, Soltani D. Meta-Analysis of the usefulness of Beta-Blockers to reduce the risk of major adverse cardiovascular events in patients with stable coronary artery disease without prior myocardial infarction or left ventricular dysfunction. Am J Cardiol. 2021;158:23\u20139.","journal-title":"Am J Cardiol"},{"issue":"5","key":"5467_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/AC.65.5.2056244","volume":"65","author":"F Gorre","year":"2010","unstructured":"Gorre F, Vandekerckhove H. Beta-blockers: focus on mechanism of action which beta-blocker, when and why? Acta Cardiol. 2010;65(5):565\u201370.","journal-title":"Acta Cardiol"},{"issue":"5","key":"5467_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1185\/03007995.2013.874993","volume":"30","author":"Z Kobalava","year":"2014","unstructured":"Kobalava Z, Khomitskaya Y, Kiyakbaev G. AchievemenT of target resting heart rate on beta-blockers in patients with stable angina and hypertension (ATHENA) in routine clinical practice in Russia. Curr Med Res Opin. 2014;30(5):805\u201311.","journal-title":"Curr Med Res Opin"},{"issue":"19","key":"5467_CR15","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa2504735","volume":"393","author":"B Ibanez","year":"2025","unstructured":"Ibanez B, Latini R, Rossello X, Dominguez-Rodriguez A, Fern\u00e1ndez-Vazquez F, Pelizzoni V, et al. Beta-Blockers after myocardial infarction without reduced ejection fraction. N Engl J Med. 2025;393(19):1889\u2013900.","journal-title":"N Engl J Med"},{"issue":"1","key":"5467_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1472-6963-5-21","volume":"5","author":"A Fretheim","year":"2005","unstructured":"Fretheim A, Oxman AD. International variation in prescribing antihypertensive drugs: its extent and possible explanations. BMC Health Serv Res. 2005;5(1):21.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"5467_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3760-z","volume":"16","author":"M Farjam","year":"2016","unstructured":"Farjam M, Bahrami H, Bahramali E, Jamshidi J, Askari A, Zakeri H, et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa cohort study. BMC Public Health. 2016;16(1):1\u20138.","journal-title":"BMC Public Health"},{"issue":"9","key":"5467_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jacc.2023.06.006","volume":"82","author":"DE Winchester","year":"2023","unstructured":"Winchester DE, Cibotti-Sun M. 2023 Chronic Coronary Disease Guideline-at-a-Glance. J Am Coll Cardiol. 2023;82(9):956\u2009\u2013\u200960.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5467_CR19","first-page":"819","volume":"83","author":"M Pflieger","year":"2011","unstructured":"Pflieger M, Winslow BT, Mills K, Dauber IM. Medical management of stable coronary artery disease. Am Fam Physician. 2011;83(7):819\u201326.","journal-title":"Am Fam Physician"},{"key":"5467_CR20","doi-asserted-by":"publisher","first-page":"b219","DOI":"10.1136\/bmj.b219","volume":"338","author":"J Hsia","year":"2009","unstructured":"Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, Hendrix SL, et al. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ. 2009;338:b219.","journal-title":"BMJ"},{"issue":"9","key":"5467_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0002-9149(90)91029-6","volume":"65","author":"\u00c5 Hjalmarson","year":"1990","unstructured":"Hjalmarson \u00c5, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol. 1990;65(9):547\u201353.","journal-title":"Am J Cardiol"},{"issue":"12","key":"5467_CR22","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1097\/HJH.0000000000001125","volume":"34","author":"B Tomlinson","year":"2016","unstructured":"Tomlinson B, Sritara P, Lopez E, Dalal J, Erwinanto E, Pancholia AK. Hypertension and elevated heart rate: focus on the Asia Pacific region. J Hypertens. 2016;34(12):2330\u20132.","journal-title":"J Hypertens"},{"issue":"1","key":"5467_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-61506-0","volume":"10","author":"MH Yazdanpanah","year":"2020","unstructured":"Yazdanpanah MH, Homayounfar R, Khademi A, Zarei F, Shahidi A, Farjam M. Short sleep is associated with higher prevalence and increased predicted risk of cardiovascular diseases in an Iranian population: Fasa PERSIAN cohort study. Sci Rep. 2020;10(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"9641","key":"5467_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Ferrari R, Investigators B. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9641):807\u201316.","journal-title":"Lancet"},{"issue":"19","key":"5467_CR25","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/eurheartj\/ehp358","volume":"30","author":"K Fox","year":"2009","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J. 2009;30(19):2337\u201345.","journal-title":"Eur Heart J"},{"issue":"1","key":"5467_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijcard.2014.06.052","volume":"176","author":"M Tendera","year":"2014","unstructured":"Tendera M, Fox K, Ferrari R, Ford I, Greenlaw N, Abergel H, et al. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry. Int J Cardiol. 2014;176(1):119\u201324.","journal-title":"Int J Cardiol"},{"issue":"10","key":"5467_CR27","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/eurheartj\/ehi109","volume":"26","author":"CA Daly","year":"2005","unstructured":"Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, Danchin N, et al. The initial management of stable angina in Europe, from the Euro heart survey: a description of Pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro heart survey of stable angina. Eur Heart J. 2005;26(10):1011\u201322.","journal-title":"Eur Heart J"},{"issue":"23","key":"5467_CR28","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1161\/CIRCULATIONAHA.107.187930","volume":"116","author":"TD Fraker Jr","year":"2007","unstructured":"Fraker TD Jr, Fihn SD, Committee WobotCSAW MEMBERSWC, Gibbons RJ, Abrams J, et al. 2007 chronic angina focused update of the ACC\/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American college of Cardiology\/American heart association task force on practice guidelines writing group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. Circulation. 2007;116(23):2762\u201372.","journal-title":"Circulation"},{"issue":"13","key":"5467_CR29","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jama.2012.12559","volume":"308","author":"S Bangalore","year":"2012","unstructured":"Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, et al. \u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13):1340\u20139.","journal-title":"JAMA"},{"issue":"6","key":"5467_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/JCN.0000000000000488","volume":"33","author":"C-Y Lin","year":"2018","unstructured":"Lin C-Y, Ou H-t, Nikoobakht M, Brostr\u00f6m A, \u00c5restedt K, Pakpour AH. Validation of the 5-item medication adherence report scale in older stroke patients in Iran. J Cardiovasc Nurs. 2018;33(6):536\u201343.","journal-title":"J Cardiovasc Nurs"},{"issue":"1","key":"5467_CR31","first-page":"269","volume":"4","author":"J Jin","year":"2008","unstructured":"Jin J, Sklar GE, Oh VMS, Li SC. Factors affecting therapeutic compliance: A review from the patient\u2019s perspective. Ther Clin Risk Manag. 2008;4(1):269.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"5467_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1871525713666141219114240","volume":"13","author":"GG Secco","year":"2015","unstructured":"Secco GG, Parisi R, Mirabella F, Rognoni A, Lupi A, De Luca G, et al. Old and new drugs for treatment of stable angina: new Anti-Anginal drugs and coronary revascularization. Cardiovasc Hematol Agents Med Chem. 2015;13(1):21\u20134.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"5467_CR33","doi-asserted-by":"crossref","unstructured":"Abbes H, Soria-Chacartegui P, Omezzine A, Abad-Santos F, Zubiaur P. Impact of genetic variation in adrenergic receptors on \u03b2-Blocker effectiveness and safety in cardiovascular disease management: A systematic review. Pharmaceuticals (Basel). 2025;18(4).","DOI":"10.3390\/ph18040493"},{"issue":"5","key":"5467_CR34","doi-asserted-by":"publisher","first-page":"e36284","DOI":"10.1371\/journal.pone.0036284","volume":"7","author":"PG Steg","year":"2012","unstructured":"Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif J-C, Tendera M, et al. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. PLoS ONE. 2012;7(5):e36284.","journal-title":"PLoS ONE"},{"issue":"1014","key":"5467_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/pgmj.2009.084384","volume":"86","author":"CA Daly","year":"2010","unstructured":"Daly CA, Clemens F, Sendon JLL, Tavazzi L, Boersma E, Danchin N, et al. Inadequate control of heart rate in patients with stable angina: results from the European heart survey. Postgrad Med J. 2010;86(1014):212\u20137.","journal-title":"Postgrad Med J"},{"issue":"11","key":"5467_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","volume":"27","author":"ATF Members","year":"2006","unstructured":"Members ATF, Fox K, Garcia MAA, Ardissino D, Buszman P, Camici PG, et al. Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. Eur Heart J. 2006;27(11):1341\u201381.","journal-title":"Eur Heart J"},{"issue":"38","key":"5467_CR37","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"TF Members","year":"2013","unstructured":"Members TF, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34(38):2949\u20133003.","journal-title":"Eur Heart J"},{"issue":"7200","key":"5467_CR38","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"Freemantle N, Cleland J, Young P, Mason J, Harrison J. \u03b2 Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318(7200):1730\u20137.","journal-title":"BMJ"},{"key":"5467_CR39","doi-asserted-by":"publisher","unstructured":"Kristensen AMD, Rossello X, Atar D, Yndigegn T, Kimura T, Latini R et al. Beta-Blockers after myocardial infarction with normal ejection fraction. N Engl J Med. 2025.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa2512686.","DOI":"10.1056\/NEJMoa2512686"},{"issue":"10","key":"5467_CR40","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","volume":"127","author":"S Bangalore","year":"2014","unstructured":"Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD, et al. Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med. 2014;127(10):939\u201353.","journal-title":"Am J Med"},{"issue":"5","key":"5467_CR41","first-page":"530","volume":"3","author":"AJ Bagnall","year":"2010","unstructured":"Bagnall AJ, Yan AT, Yan RT, Lee CH, Tan M, Baer C, et al. Optimal medical therapy for non\u2013ST-segment\u2013elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge. Circulation: Cardiovasc Qual Outcomes. 2010;3(5):530\u20137.","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"issue":"2","key":"5467_CR42","first-page":"5270","volume":"19","author":"X Cui","year":"2019","unstructured":"Cui X, Zhou X, Ma LL, Sun TW, Bishop L, Gardiner FW, et al. A nurse-led structured education program improves self-management skills and reduces hospital readmissions in patients with chronic heart failure: a randomized and controlled trial in China. Rural Remote Health. 2019;19(2):5270.","journal-title":"Rural Remote Health"},{"issue":"3","key":"5467_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2007.04.047","volume":"154","author":"PR Mitoff","year":"2007","unstructured":"Mitoff PR, Al-Hesayen A, Azevedo E, Newton GE, Mak S. Sex differences in basal hemodynamics and left ventricular function in humans with and without heart failure. Am Heart J. 2007;154(3):575\u201380.","journal-title":"Am Heart J"},{"issue":"4","key":"5467_CR44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0031-9384(97)00517-9","volume":"63","author":"AS Wells","year":"1998","unstructured":"Wells AS, Read N, Macdonald I. Effects of carbohydrate and lipid on resting energy expenditure, heart rate, sleepiness, and mood. Physiol Behav. 1998;63(4):621\u20138.","journal-title":"Physiol Behav"},{"issue":"29","key":"5467_CR45","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1093\/eurheartj\/ehw059","volume":"37","author":"B Morseth","year":"2016","unstructured":"Morseth B, Graff-Iversen S, Jacobsen BK, J\u00f8rgensen L, Nyrnes A, Thelle DS, et al. Physical activity, resting heart rate, and atrial fibrillation: the Troms\u00f8 study. Eur Heart J. 2016;37(29):2307\u201313.","journal-title":"Eur Heart J"},{"issue":"2","key":"5467_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jama.297.2.177","volume":"297","author":"JN Rasmussen","year":"2007","unstructured":"Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177\u201386.","journal-title":"JAMA"},{"issue":"17","key":"5467_CR47","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","volume":"166","author":"PM Ho","year":"2006","unstructured":"Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842\u20137.","journal-title":"Arch Intern Med"},{"issue":"15","key":"5467_CR48","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","volume":"25","author":"J L\u00f3pez-Send\u00f3","year":"2004","unstructured":"L\u00f3pez-Send\u00f3 J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, et al. Expert consensus document on \u03b2-adrenergic receptor blockers: the task force on Beta-Blockers of the European society of cardiology. Eur Heart J. 2004;25(15):1341\u201362.","journal-title":"Eur Heart J"},{"key":"5467_CR49","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/oxfordjournals.eurheartj.a015259","volume":"18","author":"Cardiology ESo","year":"1997","unstructured":"Cardiology ESo. Management of stable angina pectoris. Recommendations of the task force of the European society of cardiology. Eur Heart J. 1997;18:394\u2013413.","journal-title":"Eur Heart J"},{"issue":"14","key":"5467_CR50","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"ATF Members","year":"2012","unstructured":"Members ATF, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787\u2013847.","journal-title":"Eur Heart J"},{"issue":"2","key":"5467_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.15171\/apb.2017.024","volume":"7","author":"E Salehifar","year":"2017","unstructured":"Salehifar E, Ebrahim S, Shiran M-R, Faramarzi F, Rad HA, Avan R, et al. Pharmacokinetic parameters and over-responsiveness of Iranian population to propranolol. Adv Pharm Bull. 2017;7(2):195.","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"5467_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.vph.2005.09.010","volume":"44","author":"DK Arnett","year":"2006","unstructured":"Arnett DK, Claas SA, Glasser SP. Pharmacogenetics of antihypertensive treatment. Vascul Pharmacol. 2006;44(2):107\u201318.","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"5467_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12913-018-3009-x","volume":"18","author":"CC Chua","year":"2018","unstructured":"Chua CC, Hutchinson A, Tacey M, Parikh S, Lim WK, Aboltins C. A physician targeted intervention improves prescribing in chronic heart failure in general medical units. BMC Health Serv Res. 2018;18(1):206.","journal-title":"BMC Health Serv Res"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05467-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05467-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05467-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:03:14Z","timestamp":1769788994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05467-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5467"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05467-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in accordance with the ethical standards outlined by regional and national regulatory bodies and in full compliance with the Declaration of Helsinki. All participants provided written informed consent, and the study protocol was approved by the Ethics Committee of Fasa University of Medical Sciences (approval code: IR.FUMS.REC.1399.127), which operates as an institutional review board (IRB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}